Bodal Chemicals Posts Strong Revenue Growth But Profit Momentum Slips
Revenue jumped 57% year-on-year, yet profit fell sequentially as net profit margin retreated from the previous quarter's high.
Bodal Chemicals reported a robust 57% YoY revenue increase for Q1 FY27, though profit dipped sequentially. The net profit margin remains well above last year's level.
Bodal Chemicals kicked off FY27 with a powerful surge in sales, though profit momentum eased from the previous quarter's peak. Revenue for the June 2026 quarter soared 57% year-on-year to ₹698.3 crore, while profit after tax (PAT) grew an even stronger 178% over the same period to ₹28.78 crore. However, compared to the March 2026 quarter, revenue rose 21% while profit slipped 5.7%, indicating some pressure on profitability from the prior period's high.
The quarterly trajectory reveals a story of recovery and consolidation. After a period of very low profitability in the middle of FY26, the company's net profit margin has strengthened significantly year-on-year, rising 180 basis points to 4.1%. The latest quarter's margin, however, is down from the 5.3% achieved in Q4 FY26.
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin
| Metric | CurrentQ1 FY27 | PreviousQ4 FY26 | Same quarter LYQ1 FY26 |
|---|---|---|---|
| Revenue (₹ Cr) | 698.3YoY +57% | 577.1 | 444.85 |
| Profit (₹ Cr) | 28.78YoY +178% | 30.52 | 10.34 |
| Net Profit Margin | 4.1%YoY +78% | 5.3% | 2.3% |
Key Points
- The trailing twelve-month (TTM) net profit margin stands at 2.9%, below the latest quarter's level but a marked improvement over the full-year FY25 margin of 1.1%.
- The stock has delivered a modest 4% return over the past year and trades at a P/E of 39.8, roughly in line with the industry average.
- Balance sheet metrics show a debt-to-equity ratio of 0.82 and a return on equity (ROE) of 1.69%.
Overall, Bodal's first quarter shows a healthy top-line expansion but a step back in the exceptional profitability seen at the end of last fiscal year. The key question for the coming quarters is whether the company can sustain its elevated revenue base while rebuilding its profit margins.
Live Chart
· BODALCHEM
(BSE)
ISIN: INE338D01028
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.